Pagano et al. demonstrated in a murine model that IL-27 deficiency promoted a more immunosuppressive tumour microenvironment and accelerated CLL progression; however, their study did not specifically address the impact of IL-27 on TIM-3 expression [17]. The gene discussed is HAVCR2; the disease is B-cell chronic lymphocytic leukemia.